Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

TCDD changes skin cell growth and keratin production in mice.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Tislelizumab can cause cutaneous lupus erythematosus.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Skin cells control immune cell placement, helping the skin respond better to challenges.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

CD34 marks potential stem cells in dog hair follicles.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.